{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T01:45:45Z","timestamp":1784425545111,"version":"3.55.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008525","name":"Hebei Agricultural University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008525","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.vaccine.2024.03.048","type":"journal-article","created":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T08:29:08Z","timestamp":1711009748000},"page":"2848-2857","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Comparison of immune effects of porcine circovirus type 2d (PCV2d) capsid protein expressed by Escherichia coli and baculovirus-insect cells"],"prefix":"10.1016","volume":"42","author":[{"given":"Yawen","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaining","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinye","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.03.048_b0005","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.virusres.2011.10.007","article-title":"Porcine circovirus type 2 (PCV2) infections: clinical signs, pathology and laboratory diagnosis","volume":"164","author":"Segal\u00e9s","year":"2012","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2024.03.048_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2022.105738","article-title":"Pathomorphology, immunohistochemical, and molecular detection of an atypical porcine dermatitis and nephropathy syndrome (PDNS) due to PCV-2d-2 in naturally affected grower pigs of India","volume":"171","author":"Sahoo","year":"2022","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2024.03.048_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2020.198044","article-title":"Porcine circoviruses: current status, knowledge gaps and challenges","volume":"286","author":"Opriessnig","year":"2020","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2024.03.048_b0020","doi-asserted-by":"crossref","DOI":"10.3390\/v11020185","article-title":"Co-infection of swine with porcine circovirus type 2 and other swine viruses","volume":"11","author":"Ouyang","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2024.03.048_b0025","article-title":"Macrophage Polarization modulated by porcine circovirus type 2 facilitates bacterial coinfection","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2024.03.048_b0030","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.virusres.2009.02.009","article-title":"Porcine circoviruses\u2013small but powerful","volume":"143","author":"Finsterbusch","year":"2009","journal-title":"Virus Res"},{"issue":"1","key":"10.1016\/j.vaccine.2024.03.048_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11262-014-1099-z","article-title":"Current understanding of genomic DNA of porcine circovirus type 2","volume":"49","author":"Lv","year":"2014","journal-title":"Virus Genes"},{"key":"10.1016\/j.vaccine.2024.03.048_b0040","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.vetmic.2018.10.005","article-title":"The ORF5 protein of porcine circovirus type 2 enhances viral replication by dampening type I interferon expression in porcine epithelial cells","volume":"226","author":"Choi","year":"2018","journal-title":"Vet Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2024.03.048_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11259-017-9702-0","article-title":"Identification and functional analysis of the novel ORF6 protein of porcine circovirus type 2 in vitro","volume":"42","author":"Li","year":"2018","journal-title":"Vet Res Commun"},{"key":"10.1016\/j.vaccine.2024.03.048_b0050","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00724-18","article-title":"Crystal structure of the Dimerized N terminus of porcine circovirus type 2 replicase protein reveals a novel antiviral Interface","volume":"92","author":"Luo","year":"2018","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2024.03.048_b0055","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01836-19","article-title":"Neutralization mechanism of a monoclonal antibody Targeting a porcine circovirus type 2 cap protein conformational epitope","volume":"94","author":"Huang","year":"2020","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2024.03.048_b0060","first-page":"e0076321","article-title":"Mechanism of DNA Interaction and translocation by the replicase of a Circular rep-encoding single-stranded DNA virus","volume":"12","author":"Tarasova","year":"2021","journal-title":"Microbiology"},{"key":"10.1016\/j.vaccine.2024.03.048_b0065","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.virol.2015.01.004","article-title":"Specific functions of the rep and rep\u05f3 proteins of porcine circovirus during copy-release and rolling-circle DNA replication","volume":"481","author":"Cheung","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2024.03.048_b0070","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1186\/s12951-022-01710-4","article-title":"A modular and self-adjuvanted multivalent vaccine platform based on porcine circovirus virus-like nanoparticles","volume":"20","author":"Liu","year":"2022","journal-title":"J Nanobiotechnol"},{"issue":"13","key":"10.1016\/j.vaccine.2024.03.048_b0075","doi-asserted-by":"crossref","first-page":"8262","DOI":"10.1128\/JVI.79.13.8262-8274.2005","article-title":"Characterization of a previously unidentified viral protein in porcine circovirus type 2-infected cells and its role in virus-induced apoptosis","volume":"79","author":"Liu","year":"2005","journal-title":"Journal Virol"},{"issue":"7","key":"10.1016\/j.vaccine.2024.03.048_b0080","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1099\/jgv.0.000472","article-title":"The ORF4 protein of porcine circovirus type 2 antagonizes apoptosis by stabilizing the concentration of ferritin heavy chain through physical interaction","volume":"97","author":"Lv","year":"2016","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2024.03.048_b0085","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1007\/s00253-012-4015-2","article-title":"Characterization of porcine circovirus type 2 (PCV2) capsid particle assembly and its application to virus-like particle vaccine development","volume":"95","author":"Wu","year":"2012","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.vaccine.2024.03.048_b0090","doi-asserted-by":"crossref","first-page":"e383","DOI":"10.1111\/tbed.12768","article-title":"Phylogenetic and genetic variation analyses of porcine circovirus type 2 isolated from China","volume":"65","author":"Yang","year":"2018","journal-title":"Transbound Emerg Dis"},{"key":"10.1016\/j.vaccine.2024.03.048_b0095","doi-asserted-by":"crossref","first-page":"e0208585","DOI":"10.1371\/journal.pone.0208585","article-title":"Porcine circovirus 2 (PCV-2) genotype update and proposal of a new genotyping methodology","volume":"13","author":"Franzo","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2024.03.048_b0100","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ympev.2016.04.028","article-title":"Phylodynamic analysis of porcine circovirus type 2 reveals global waves of emerging genotypes and the circulation of recombinant forms","volume":"100","author":"Franzo","year":"2016","journal-title":"Mol Phylogenet Evol"},{"key":"10.1016\/j.vaccine.2024.03.048_b0105","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.vetmic.2012.12.033","article-title":"The natural history of porcine circovirus type 2: from an inoffensive virus to a devastating swine disease?","volume":"165","author":"Segal\u00e9s","year":"2013","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2024.03.048_b0110","doi-asserted-by":"crossref","DOI":"10.3390\/v9050099","article-title":"Porcine circovirus type 2 (PCV2) vaccines in the context of current Molecular epidemiology","volume":"9","author":"Karuppannan","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2024.03.048_b0115","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12917-020-02718-4","article-title":"Epidemiological investigation of porcine circovirus type 2 and its coinfection rate in Shandong province in China from 2015 to 2018","author":"Ma","year":"2021","journal-title":"BMC Vet Res"},{"key":"10.1016\/j.vaccine.2024.03.048_b0120","doi-asserted-by":"crossref","first-page":"e41463","DOI":"10.1371\/journal.pone.0041463","article-title":"A porcine circovirus type 2 (PCV2) mutant with 234 amino acids in capsid protein showed more virulence in vivo, compared with classical PCV2a\/b strain","volume":"7","author":"Guo","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2024.03.048_b0125","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.vetmic.2012.12.019","article-title":"Emergence of a novel mutant PCV2b variant associated with clinical PCVAD in two vaccinated pig farms in the U.S. concurrently infected with PPV2","volume":"163","author":"Opriessnig","year":"2013","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2024.03.048_b0130","doi-asserted-by":"crossref","first-page":"12469","DOI":"10.1128\/JVI.02345-12","article-title":"Complete genome sequence of a novel porcine circovirus type 2b variant present in cases of vaccine failures in the United States","volume":"86","author":"Xiao","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2024.03.048_b0135","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1186\/s12917-020-02549-3","article-title":"Genetic diversity and different cross-neutralization capability of porcine circovirus type 2 isolates recently circulating in South Korea","volume":"16","author":"Kang","year":"2020","journal-title":"BMC Vet Res"},{"key":"10.1016\/j.vaccine.2024.03.048_b0140","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1186\/s12917-020-02527-9","article-title":"PCV cap proteins fused with calreticulin expressed into polymers in Escherichia coli with high immunogenicity in mice","volume":"16","author":"Liu","year":"2020","journal-title":"BMC Vet Res"},{"key":"10.1016\/j.vaccine.2024.03.048_b0145","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1089\/vim.2019.0201","article-title":"Reduction of postweaning multisystemic wasting syndrome-associated clinical symptoms by virus-like Particle vaccine against porcine Parvovirus and porcine circovirus type 2","volume":"33","author":"Liu","year":"2020","journal-title":"Viral Immunol"},{"key":"10.1016\/j.vaccine.2024.03.048_b0150","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12917-023-03648-7","article-title":"Production of virus-like particles of porcine circovirus 2 in baculovirus expression system and its application for antibody detection","volume":"19","author":"Li","year":"2023","journal-title":"BMC Vet Res"},{"key":"10.1016\/j.vaccine.2024.03.048_b0155","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13567-020-00836-3","article-title":"Construction of polycistronic baculovirus surface display vectors to express the PCV2 Cap(d41) protein and analysis of its immunogenicity in mice and swine","volume":"51","author":"Chen","year":"2020","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2024.03.048_b0160","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.virusres.2016.06.002","article-title":"Characterization of anti-porcine epidemic diarrhea virus neutralizing activity in mammary secretions","volume":"226","author":"Song","year":"2016","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2024.03.048_b0165","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/j.vaccine.2020.01.013","article-title":"Porcine circovirus type 2a or 2b based experimental vaccines provide protection against PCV2d\/porcine parvovirus 2 co-challenge","volume":"38","author":"Opriessnig","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.03.048_b0170","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s12917-020-02413-4","article-title":"Porcine circovirus type 2 (PCV2) genotyping in austrian pigs in the years 2002 to 2017","volume":"16","author":"Weissenbacher-Lang","year":"2020","journal-title":"BMC Vet Res"},{"key":"10.1016\/j.vaccine.2024.03.048_b0175","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.vetmic.2016.11.009","article-title":"PCV2d-2 is the predominant type of PCV2 DNA in pig samples collected in the U.S. during 2014\u20132016","volume":"197","author":"Xiao","year":"2016","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2024.03.048_b0180","doi-asserted-by":"crossref","first-page":"482","DOI":"10.4014\/jmb.1809.09032","article-title":"Comparison of immune responses to the PCV2 replicase-capsid and capsid virus-like Particle vaccines in mice","volume":"29","author":"Jung","year":"2019","journal-title":"J Microbiol Biotechnol"},{"key":"10.1016\/j.vaccine.2024.03.048_b0185","doi-asserted-by":"crossref","first-page":"1077026","DOI":"10.3389\/fmicb.2022.1077026","article-title":"The ultrasonically treated nanoliposomes containing PCV2 DNA vaccine expressing gC1qR binding site mutant cap is efficient in mice","volume":"13","author":"Du","year":"2022","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2024.03.048_b0190","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2147\/IJN.S357462","article-title":"Targeted delivery of nanovaccine to dendritic cells via DC-binding peptides induces potent antiviral immunity in vivo","volume":"17","author":"Lu","year":"2022","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.vaccine.2024.03.048_b0195","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s40813-021-00213-2","article-title":"Exploratory field study on the effects of porcine circovirus 2 (PCV-2) sow vaccination at different physiological stages mimicking blanket vaccination","volume":"7","author":"Pleguezuelos","year":"2021","journal-title":"Porcine health management"},{"key":"10.1016\/j.vaccine.2024.03.048_b0200","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.virusres.2017.12.012","article-title":"Nuclear localization signal regulates porcine circovirus type 2 capsid protein nuclear export through phosphorylation","volume":"246","author":"Hou","year":"2018","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2024.03.048_b0205","first-page":"14","article-title":"Carboxyl-terminal decoy epitopes in the capsid protein of porcine circovirus type 2 are immunogenicity-enhancers that elicit predominantly specific antibodies in non-vaccinated pigs","author":"Hung","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2024.03.048_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.vetmic.2022.109410","article-title":"Efficient production and characterization of immunogenic HEV-PCV2 chimeric virus-like particles","volume":"268","author":"Baha","year":"2022","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2024.03.048_b0215","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jbiotec.2016.01.017","article-title":"Efficient expression and purification of porcine circovirus type 2 virus-like particles in Escherichia coli","volume":"220","author":"Wu","year":"2016","journal-title":"J Biotechnol"},{"key":"10.1016\/j.vaccine.2024.03.048_b0220","doi-asserted-by":"crossref","first-page":"e1007562","DOI":"10.1371\/journal.ppat.1007562","article-title":"Structural roles of PCV2 capsid protein N-terminus in PCV2 particle assembly and identification of PCV2 type-specific neutralizing epitope","volume":"15","author":"Mo","year":"2019","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2024.03.048_b0225","doi-asserted-by":"crossref","first-page":"4839","DOI":"10.3390\/v6124839","article-title":"Virus-like particles of chimeric recombinant porcine circovirus type 2 as antigen vehicle carrying foreign epitopes","volume":"6","author":"Zhang","year":"2014","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2024.03.048_b0230","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12917-023-03581-9","article-title":"Matrine combined with osthole inhibited the PERK apoptosis of splenic lymphocytes in PCV2-infected mice model","volume":"19","author":"Xu","year":"2023","journal-title":"BMC Vet Res"},{"key":"10.1016\/j.vaccine.2024.03.048_b0235","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/1743-422X-7-158","article-title":"A mouse model to study infection against porcine circovirus type 2: viral distribution and lesions in mouse","volume":"7","author":"Li","year":"2010","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2024.03.048_b0240","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1515\/pjvs-2017-0004","article-title":"Germocyte lesions caused by porcine circovirus type 2b in Kunming mice","volume":"20","author":"Yuan","year":"2017","journal-title":"Pol J Vet Sci"},{"key":"10.1016\/j.vaccine.2024.03.048_b0245","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/1348-0421.12158","article-title":"Protective immunity conferred by porcine circovirus 2 ORF2-based DNA vaccine in mice","volume":"58","author":"Sylla","year":"2014","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2024.03.048_b0250","doi-asserted-by":"crossref","first-page":"195","DOI":"10.24425\/pjvs.2022.141803","article-title":"Evaluation of the protective efficacy of virus-like particles based on PCV 2b and 2d subtypes against mixed challenge in mice","volume":"25","author":"Yuan","year":"2022","journal-title":"Pol J Vet Sci"},{"key":"10.1016\/j.vaccine.2024.03.048_b0255","doi-asserted-by":"crossref","first-page":"5615","DOI":"10.1016\/j.vaccine.2021.08.013","article-title":"Cellular and humoral immunity following vaccination with two different PCV2 vaccines (containing PCV2a or PCV2a\/PCV2b) and challenge with virulent PCV2d","volume":"39","author":"Venegas-Vargas","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.03.048_b0260","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1007\/s00705-018-3735-8","article-title":"Reduced antigen presentation capability and modified inflammatory\/immunosuppressive cytokine expression of induced monocyte-derived dendritic cells from peripheral blood of piglets infected with porcine circovirus type 2","volume":"163","author":"Yang","year":"2018","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2024.03.048_b0265","first-page":"11","article-title":"Porcine circovirus type 2 rep enhances IL-10 production in macrophages via activation of p38-MAPK pathway","author":"Wu","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2024.03.048_b0270","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4142\/jvs.2010.11.3.177","article-title":"Distribution and characterization of IL-10-secreting cells in lymphoid tissues of PCV2-infected pigs","volume":"11","author":"Doster","year":"2010","journal-title":"J Vet Sci"},{"key":"10.1016\/j.vaccine.2024.03.048_b0275","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40813-015-0012-z","article-title":"Porcine circovirus 2 immunology and viral evolution","volume":"1","author":"Kekarainen","year":"2015","journal-title":"Porcine health management"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24003347?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24003347?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,13]],"date-time":"2024-04-13T04:16:16Z","timestamp":1712981776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24003347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":55,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0264410X24003347"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.03.048","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of immune effects of porcine circovirus type 2d (PCV2d) capsid protein expressed by Escherichia coli and baculovirus-insect cells","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.03.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}